Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR-/- mice
Date
2023-03-09
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Thompson, D, Mahmood, S, Morrice, N, Kamli-Salino, S, Dekeryte, R, Hoffmann, P, Doherty, M K, Whitfield, P D, Delibegović, M & Mody, N 2023, 'Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR-/- mice', Scientific Reports, vol. 13, 3937. https://doi.org/10.1101/2022.07.22.500933, https://doi.org/10.1038/s41598-023-30759-w